As of 3:41pm ET
| +0.12 / +5.31%|
The 1 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 4.50, with a high estimate of 4.50 and a low estimate of 4.50. The median estimate represents a +89.08% increase from the last price of 2.38.
The current consensus among 1 polled investment analysts is to Hold stock in CorMedix Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.